Key Takeaways
- Micron’s fiscal fourth quarter earnings arrive Wednesday, September 30, with shares priced at $1,082.28.
- JPMorgan maintains its Overweight stance with a $1,540 price objective prior to the release.
- Wall Street forecasts $51.4 billion in revenue and earnings per share of $31.73, surpassing company guidance.
- Option market participants anticipate approximately 8% volatility following the announcement.
- The company’s HBM3E and HBM4 memory production is completely reserved through 2027.
Trading at $1,082.28 before Wednesday’s quarterly report, Micron commands a market capitalization approaching $1.22 trillion. This valuation follows an extraordinary 589% climb over the preceding twelve months, placing it among the top-performing large-cap equities during that period.
JPMorgan confirmed its Overweight designation Wednesday morning while maintaining a $1,540 price objective. The investment bank contends Micron remains attractively valued despite its substantial rally.
Street consensus calls for fiscal fourth quarter revenue reaching $51.4 billion. This represents a dramatic increase from the year-ago figure of $11.32 billion, marking approximately 351% growth.
Adjusted profit per share is projected at $31.73, compared to $3.03 during the equivalent quarter last year. Gross margin estimates center around 86.2%.
JPMorgan noted that pricing strength persisted throughout the period. While management previously indicated a deceleration in price appreciation rates, the firm interprets this as a customer engagement tactic rather than evidence of weakening demand.
Key Metrics Analysts Will Monitor Beyond Core Results
JPMorgan anticipates Micron will elevate its November quarter projections. This expectation stems from strengthening customer demand indicators and management’s perspective that 2027 memory supply conditions will be tighter than 2026.
The firm also highlighted sustained traction in HBM4, Micron’s high-bandwidth memory designed for AI applications. Micron delivered over $1 billion in HBM4 shipments by the May quarter.
Future bit production secured under supply contracts now reaches approximately 35%. This marks an increase from roughly 20% of DRAM volumes and 33% of NAND volumes reported in the previous quarter.
Competing Wall Street analysts share similar optimism. UBS maintains a Buy recommendation with a $1,625 objective, emphasizing robust DRAM and server demand. Wells Fargo reduced its target to $1,400 from $1,525 while preserving an Overweight rating and lifting 2027 and 2028 projections.
Stifel carries a $1,500 target and anticipates both actual results and forward guidance will exceed consensus, though it noted potential margin moderation linked to supply limitations. TD Cowen preserved its $1,600 target, highlighting supportive demand despite slower margin expansion than previously.
Historical Patterns Point to Significant Post-Earnings Movement
Options pricing implies an approximately 8.6% potential move in either direction following the earnings announcement, translating to roughly $93 per share. This closely mirrors Micron’s historical performance.
Across the previous 14 earnings releases, Micron closed higher the next trading day 6 times and lower 8 times, per TipRanks data. The mean one-day movement, irrespective of direction, measured approximately 8.4%.
Following the prior quarterly report, shares surged roughly 16% in the subsequent session. This type of movement explains why options traders are preparing for similar volatility this week.
Beyond immediate quarterly metrics, Micron confirmed its HBM3E and HBM4 production capacity is fully committed through the entirety of calendar 2027. HBM4E development continues progressing toward volume manufacturing scheduled for 2027.
The chipmaker recently showcased what it described as the industry’s first 512GB DDR5 RDIMM, currently undergoing validation by AMD and Intel. Micron has also committed to over $250 billion in planned domestic investment extending through 2035.
Analyst consensus on Micron registers as Strong Buy, derived from 20 firms covering the stock. This comprises 19 Buy recommendations, one Hold rating, and zero Sell ratings, with a mean price objective of $1,501.84.





